Metabolomic patterns associated to QTc interval in shiftworkers: an explorative analysis

References

• Akanji A, Humphreys S, Thursfield V, et al. (1989). The relationship of plasma acetate with glucose and other blood intermediary metabolites in non-diabetic and diabetic subjects. Clin Chim Acta 185:25–34.
   PubMed Web of Science ®Google Scholar
• Anastasovska J, Arora T, Sanchez Canon GJ, et al. (2012). Fermentable carbohydrate alters hypothalamic neuronal activity and protects against the obesogenic environment. Obesity (Silver Spring) 20:1016–23.
   PubMed Web of Science ®Google Scholar
• Barison A, Vergaro G, Pastormerlo LE, et al. (2011). Markers of arrhythmogenic risk in hypertensive subjects. Curr Pharm Des 17:3062–73.
   PubMed Web of Science ®Google Scholar
• Barker M, Rayens W. (2003). Partial least squares for discrimination. J Chemom 17:166–73.
   Web of Science ®Google Scholar
• Bonvallot N, Tremblay-Franco M, Chevrier C, et al. (2013). Metabolomics tools for describing complex pesticide exposure in pregnant women in Brittany (France). PLoS One 8:e64433.
   PubMedGoogle Scholar
• Dudka I, Kossowska B, Senhadri H, et al. (2014). Metabonomic analysis of serum of workers occupationally exposed to arsenic, cadmium and lead for biomarker research: a preliminary study. Environ Int 68:71–81.
   PubMed Web of Science ®Google Scholar
• Dunn WB, Broadhurst DI, Atherton HJ, et al. (2011). Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopy. Chem Soc Rev 40:387–426.
   PubMed Web of Science ®Google Scholar
• el-Gamal A, Gallagher D, Nawras A, et al. (1995). Effects of obesity on QT, RR, and QTc intervals. Am J Cardiol 75:956–9.
   PubMed Web of Science ®Google Scholar
• Eriksson L, Johansson E, Kettaneh-Wold N, et al. (2013). Multi- and megavariate data analysis. 3rd ed. Malmö, Sweden: Umetrics Academy.
   Google Scholar
• Faramawi MF, Wildman RP, Gustat J, et al. (2008). The association of the metabolic syndrome with QTc interval in NHANES III. Eur J Epidemiol 23:459–65.
   PubMed Web of Science ®Google Scholar
• Fiorentini A, Pierciaccante A, Valente R, et al. (2010). The correlation among QTc interval, hyperglycaemia and the impaired autonomic activity. Auton Neurosci 154:94–8.
   PubMed Web of Science ®Google Scholar
• Frost P, Kolstad HA, Bonde JP. (2009). Shift work and the risk of ischemic heart disease – a systematic review of the epidemiologic evidence. Scand J Work Environ Health 35:163–79.
   PubMed Web of Science ®Google Scholar
• Frost G, Sleeth ML, Sahuri-Arisoylu M, et al. (2013). The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism. Nat Commun 5:1–11.
   Google Scholar
• Giorgi MA, Bolaños R, Gonzalez CD, et al. (2010). QT interval prolongation: preclinical and clinical testing arrhythmogenesis in drugs and regulatory implications. Curr Drug Saf 5:54–7.
   PubMedGoogle Scholar
• Grandinetti A, Chang HK, Theriault A, et al. (2005). Metabolic syndrome in a multiethnic population in rural Hawaii. Ethn Dis 15:233–7.
   PubMed Web of Science ®Google Scholar
• Holmes E, Wilson ID, Nicholson JK. (2008). Metabolic phenotyping inhealth and disease. Cell 5:714–7.
   Web of Science ®Google Scholar
• Isbister GK, Page CB. (2012). Drug induced QT prolongation: the measurement and assessment of the QT interval in clinical practice. Br J Clin Pharmacol 76:48–57.
   Web of Science ®Google Scholar
• Italian Drug Agency. (2008). Linee guida sulla classificazione e conduzione degli studi osservazionali sui farmaci. Gazzetta Ufficiale della Repubblica Italiana. Serie Generale N 76 Rome, Italy: Istituto poligrafico e zecca dello Stato.
   Google Scholar
• Kannankeril P, Roden DM, Darbar D. (2010). Drug-induced long QT syndrome. Pharmacol Rev 62:760–81.
   PubMed Web of Science ®Google Scholar
• Kubiak T, Wittig A, Koll C, et al. (2010). Continuous glucose monitoring reveals associations of glucose levels with QT interval length. Diabetes Technol Ther 12:283–6.
   PubMed Web of Science ®Google Scholar
• Li W, Bai Y, Sun K, et al. (2009). Patients with Metabolic syndrome have prolonged corrected QT interval (QTc). Clin Cardiol 32:93–9.
   Google Scholar
• Lindon JC, Nicholson JK. (2008). Spectroscopic and statistical techniques for information recovery in metabonomics and metabolomics. Annu Rev Anal Chem (Palo Alto Calif) 1:45–69.
   PubMed Web of Science ®Google Scholar
• Meloni M, Setzu D, Del Rio A, et al. (2013). QTc interval and electrocardiographic changes by type of shift work. Am J Ind Med 56:1174–9.
   PubMed Web of Science ®Google Scholar
• Murata K, Yano E, Hashimoto H, et al. (2005). Effects of shift work on QTc interval and blood pressure in relation to heart rate variability. Int Arch Occup Environ Health 78:287–92.
   PubMed Web of Science ®Google Scholar
• Murata K, Yano E, Shinozaki T. (1999). Cardiovascular dysfunction due to shift work. J Occup Environ Med 41:748–53.
   PubMed Web of Science ®Google Scholar
• Park J, Noh K, Lee HW, et al. (2013). Pharmacometabolomic approach to predict QT prolongation in guinea pigs. PLoS One 8:e60556.
   Google Scholar
• Queen SR, Smulevitz B, Rentfro AR, et al. (2012). Electrocardiographic abnormalities among mexican americans: correlations with diabetes, obesity, and the metabolic syndrome. World J Cardiovasc Dis 2:50–6.
   PubMedGoogle Scholar
• Rasmiena AA, Ng TW, Meikle PJ. (2013). Metabolomics and ischaemic heart disease. Clin Sci (Lond) 124:289–306.
   PubMed Web of Science ®Google Scholar
• Rautaharju PM, Surawicz B, Gettes LS, et al. (2009). American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; American College of Cardiology Foundation; Heart Rhythm Society. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part IV: the ST segment, T and U waves, and the QT interval: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology. J Am Coll Cardiol 17:982–91.
   Web of Science ®Google Scholar
• Silva AR, Silva CG, Ruschel C, et al. (2001). l-Pyroglutamic acid inhibits energy production and lipid synthesis in cerebral cortex of young rats in vitro. Neurochem Res 26:1277–83.
   PubMed Web of Science ®Google Scholar
• The ACCORD Study Group. (2011). Long-term effects of intensive glucose lowering on cardiovascular outcomes. NEJM 364:818–28.
   PubMed Web of Science ®Google Scholar
• Vlaanderen J, Moore LE, Smith MT, et al. (2010). Application of omics technologies in occupational and environmental health research; current status and projections. Occup Environ Med 67:136–43.
   PubMed Web of Science ®Google Scholar
• Wang KC, Kuo CH, Tian TF, et al. (2012). Metabolomic characterization of laborers exposed to welding fumes. Chem Res Toxicol 25:676–86.
   PubMed Web of Science ®Google Scholar
• WHO (World Health Organization). (2011). Global atlas on cardiovascular disease prevention and control. Geneva: WHO.
   Google Scholar
• Wishart DS, Knox C, Guo AC, et al. (2009). HMDB: a knowledgebase for the human metabolome. Nucleic Acids Res 37:603–10.
   PubMed Web of Science ®Google Scholar
• Yap YG, Camm AJ. (2003). Drug induced QT prolongation and torsades de pointes. Heart 89:1363–72.
   PubMed Web of Science ®Google Scholar
• Yoshinari O, Igarashi K. (2011). Anti-diabetic effect of pyroglutamic acid in type 2 diabetic Goto-Kakizaki rats and KK-Ay mice. Br J Nutr 106:995–1004.
   PubMed Web of Science ®Google Scholar